
|Articles|June 1, 2001
The American Journal of Managed Care
- June 2001
- Volume 7
- Issue 6
Effect of Rofecoxib Therapy on Measures of Health-Related Quality of Life in Patients with Osteoarthritis
Advertisement
Articles in this issue
over 24 years ago
Does the HEDIS Asthma Measure Go Far Enough?over 24 years ago
Rheumatoid Arthritis: Guidelines for Emerging TherapiesNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
FDA Grants Breakthrough Therapy Designation to R-DXd in CDH6-Expressing Ovarian Cancer
5